ClinicalTrials.gg
Drug

Indisulam clinical trials

Also written E7070.

studies test it
11
open now
0
in phase 3
0
first study started
1998

How each study uses indisulam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

indisulam
3

Development codes

E7070
7

Studies by the year they started

11 studies that test it; most in 1998 (2)

Studies that test indisulam, by start year
YearStudies
19982
20011
20021
20032
20042
20052
20131

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 4

Eisai Inc. (3) · Eisai Limited (3) · European Organisation for Research and Treatment of Cancer - EORTC (3) · M.D. Anderson Cancer Center (1) · Eisai Co., Ltd. (1)

Often tested with

Tested in the same studies.

Irinotecan (1)

Studies

Open first, then newest update. How each study uses indisulam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Codes

What other systems call indisulam · ClinicalTrials.gg INT004399

  • UNII (FDA) WJ98J3NM90INDISULAMConfirmed FDA, Wikidata
  • Wikidata Q27078056indisulamConfirmed FDA, Wikidata
  • NCI Thesaurus C25797IndisulamOne source FDA
  • DrugBank DB06370One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.